<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>In this study we sought to determine the <z:hpo ids='HP_0011009'>acute</z:hpo> cerebrovascular effects of intracarotid <z:chebi fb="3" ids="16335">adenosine</z:chebi> by using real-time cerebral blood flow (CBF) measurements in nonhuman primates </plain></SENT>
<SENT sid="1" pm="."><plain>The internal carotid arteries of healthy anesthetized baboons were transfemorally cannulated </plain></SENT>
<SENT sid="2" pm="."><plain>Changes in CBF were continuously measured at baseline and with 6 increasing doses of <z:chebi fb="3" ids="16335">adenosine</z:chebi> (0.002 to 1.5 mg/min) by use of an intraparenchymal thermal diffusion (TD) probe </plain></SENT>
<SENT sid="3" pm="."><plain>Each infusion lasted 5 min </plain></SENT>
<SENT sid="4" pm="."><plain>At baseline and at the largest dose of <z:chebi fb="3" ids="16335">adenosine</z:chebi>, CBF was also determined by the intraarterial (133)Xe technique </plain></SENT>
<SENT sid="5" pm="."><plain>TD measurements revealed a dose-dependent increase in CBF from 32 +/- 6 mL x l00 g(-1) x min(-1) at baseline to 90 +/- 38 mL x l00 g(-1) x min(-1) with the largest dose of <z:chebi fb="3" ids="16335">adenosine</z:chebi> (n = 5; P &lt; 0.0001) </plain></SENT>
<SENT sid="6" pm="."><plain>A similar magnitude of increase in CBF was also observed with (133)Xe CBF measurements </plain></SENT>
<SENT sid="7" pm="."><plain>No significant increases in intracranial pressure or adverse systemic hemodynamic side effects were observed during <z:chebi fb="3" ids="16335">adenosine</z:chebi> infusion </plain></SENT>
<SENT sid="8" pm="."><plain>The increase in CBF after <z:chebi fb="3" ids="16335">adenosine</z:chebi> lasted only for the duration of drug infusion </plain></SENT>
<SENT sid="9" pm="."><plain>In conclusion, the transient cerebrovascular effects of intracarotid <z:chebi fb="3" ids="16335">adenosine</z:chebi> make it suitable for a trial of intraarterial <z:chebi fb="1" ids="35620">vasodilator</z:chebi> therapy and for controlled manipulation of cerebrovascular resistance </plain></SENT>
<SENT sid="10" pm="."><plain>IMPLICATIONS: Using a real-time cerebral blood flow (CBF) measurement technique, we evaluated the <z:hpo ids='HP_0011009'>acute</z:hpo> cerebrovascular effects of intracarotid <z:chebi fb="3" ids="16335">adenosine</z:chebi> in anesthetized baboons </plain></SENT>
<SENT sid="11" pm="."><plain>The increase in CBF lasted only for the duration of the <z:chebi fb="3" ids="16335">adenosine</z:chebi> infusion </plain></SENT>
<SENT sid="12" pm="."><plain><z:chebi fb="3" ids="16335">Adenosine</z:chebi> might be a suitable drug for trial as an intraarterial <z:chebi fb="1" ids="35620">vasodilator</z:chebi> for the treatment of <z:e sem="disease" ids="C0265110" disease_type="Disease or Syndrome" abbrv="">cerebral vasospasm</z:e> </plain></SENT>
</text></document>